The 15-year data help support the idea that each test can aid in putting the other’s results in perspective, but questions ...

Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with type 2 diabetes.

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.

WASHINGTON, DC—New data from the PARTNER 3 low-risk trial of patients with symptomatic, severe aortic stenosis show that TAVI ...

Amidst stalled progress on reducing CV mortality, there remains work to do on easing the financial burden on patients.

A study of more than 20,000 Californians shows that outcomes are better when echo is done at the recommended intervals.

Diastolic BP was higher years after giving birth for women who reported stress—but only if they’d had a complicated pregnancy ...

Women had better self-care at 5 years with self-expanding valves, raising questions about lower gradients and stroke impacts.

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

In the diverse cohort, risks were particularly amplified in Black Americans, likely due to structural and environmental factors.

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.

Jonathan Cunningham discusses how AI might help, from patient selection to event adjudication.